ED
RPC

Exane Derivatives’s Ridgepost Capital RPC Stock Holding History

Exane Derivatives’s Portfolio RPC Stock Details RPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$62K Buy
+5,573
New +$63.9K 0.04% 300

Other funds holding RPC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altai Capital Management West Hollywood, California $35M AUM 28.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CC
Conversant Capital Summit, New Jersey $745M AUM 20.03% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SPC
Stone Point Capital Greenwich, Connecticut $21.9M AUM 47.18% 1-Year Est. Return

Exane Derivatives's RPC Position: Q2 2022 in Review

Exane Derivatives opened a new position in Ridgepost Capital (RPC) in Q2 2022: 5,573 shares worth $62K. The stake represents 0.04% of the portfolio and ranks #300 among its holdings.

47 funds tracked by Wall St. Rank hold RPC as of Q2 2022.

  • Exane Derivatives held 5,573 shares of Ridgepost Capital worth $62K as of Q2 2022.
  • Ridgepost Capital was a new Exane Derivatives position in Q2 2022.
  • Ridgepost Capital made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #300 holding.
  • 47 funds tracked by Wall St. Rank held Ridgepost Capital as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.